Central and Peripheral Endocannabinoids and Cognate Acylethanolamides in Humans: Association with Race, Adiposity, and Energy Expenditure
Reiner Jumpertz von Schwartzenberg(German Centre for Cardiovascular Research), Jonathan Krakoff(National Institute of Diabetes and Digestive and Kidney Diseases), Daniele Piomelli(University of California, Irvine), Richard E. Pratley(Translational Research Institute for Metabolism and Diabetes), Ana Guijarro(University of Genoa)
Cited by 50
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|850